Immunic, Inc. (IMUX): Operating Cash Flow
-$85.81M
Year ended 2025-12-31
-$87.72M
Trailing 12 months to 2026-06-30
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$85.81M | n/m | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | -$84.77M | n/m | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | -$70.83M | n/m | 2025-03-31, From 2023-01-01 |
| 2022-12-31 | -$65.14M | n/m | 2024-02-22, From 2022-01-01 |
| 2021-12-31 | -$83.23M | n/m | 2023-02-23, From 2021-01-01 |
| 2020-12-31 | -$46.12M | n/m | 2022-02-24, From 2020-01-01 |
| 2019-12-31 | -$28.55M | n/m | 2021-02-26, From 2019-01-01 |
| 2018-12-31 | -$9.74M | n/m | 2020-03-16, From 2018-01-01 |
| 2017-12-31 | -$40.40M | n/m | 2019-03-04, From 2017-01-01 |
| 2016-12-31 | -$35.77M | n/m | 2019-03-04, From 2016-01-01 |
| 2015-12-31 | -$49.95M | n/m | 2018-03-13, From 2015-01-01 |
| 2014-12-31 | -$40.83M | n/m | 2017-03-07, From 2014-01-01 |
| 2013-12-31 | -$28.65M | n/m | 2016-03-08, From 2013-01-01 |
| 2012-12-31 | -$9.24M | n/a | 2015-03-20, From 2012-01-01 |
Operating Cash Flow at similar companies
| Company | Year ended | Operating Cash Flow | Change YoY |
|---|---|---|---|
| Immunic, Inc. (IMUX) | 2025-12-31 | -$85.81M | n/m |
| Rein Therapeutics, Inc. (RNTX) | 2025-12-31 | -$19.36M | n/m |
| Kiora Pharmaceuticals Inc (KPRX) | 2025-12-31 | -$9.96M | n/m |
| HCW Biologics Inc. (HCWB) | 2025-12-31 | -$13.39M | n/m |
| Integrated Biopharma Inc (INBP) | 2025-06-30 | $2.06M | +119.0% |
| Onconetix, Inc. (ONCO) | 2025-12-31 | -$9.68M | n/m |
| Faeth Therapeutics, Inc. (FTH) | 2025-12-31 | -$20.45M | n/m |
| CervoMed Inc. (CRVO) | 2025-12-31 | -$23.45M | n/m |
| Gain Therapeutics, Inc. (GANX) | 2025-12-31 | -$18.47M | n/m |
Compare IMUX, RNTX, KPRX, HCWB side by side · Screen every company in Pharmaceutical Preparations ↗